Imagine if we could help others detect OA earlier, develop better, more personalized treatments and one day, find a cure? You can help make this a reality!
The Arthritis Society has committed to funding three years of the PREDICT Study. Our goal is to raise $20,000 by May 11, 2021 to fund one year of the project.
Why fund The PREDICT Study?
Dr. Abouelseoud is developing a predictive test for osteoarthritis (OA). This test looks for biomarkers in the blood to predict who will develop hip or knee OA that progresses quickly, putting them at risk of early cartilage damage.
Osteoarthritis is the most common form of arthritis. Nearly 5 million Canadians have OA. That’s more than all other forms of arthritis combined. There is no cure for OA.
Early detection of OA is key for treatment. Without this early prediction test, many patients wait until they are experiencing OA pain to get a diagnosis, which means their disease has already progressed. For some, it is too late to prevent permanent joint damage.
This research will lead to better quality of life for Canadians with arthritis. This new test would help identify who needs to be treated more aggressively and map out a personalized treatment plan for patients to better manage OA symptoms and reduce disability from the disease.
Additionally, the PREDICT Study may uncover new knowledge about the cause of OA, leading to a cure for the disease.
If 200 donors come together and give $100 each, our community of supporters will fully fund one year of this innovative research project.